Volume: 9 Issue: 1
Year: 2021, Page: 84-86, Doi: https://doi.org/10.47799/pimr.0901.17
Received: Jan. 22, 2021 Accepted: March 27, 2021 Published: March 27, 2021
The most common benign cardiac tumor is cardiac myxoma,accounting for around 50% of all primary cardiac tumors. Cardiac myxoma is an uncommon cause ofcardioembolic stroke.Overall,cardioembolic stroke accounts for approximately 30% of all ischemic stroke of which 0.5% of cardioembolic strokes are attributable to a cardiac myxoma.It has an annual incidence of around 0.5 cases per one million people with female predominance. Early diagnosis is necessary to prevent its devastating complications such as embolic stroke and sudden cardiac death.We present a relatively rare case of an acute stroke as a first and only manifestation of an atrial myxoma.
Keywords:
1. Reynen K. Cardiac myxomas. N Engl J Med 1995;333:1610- 7.
2. Allard MF, Taylor GP, Wilson JE, McManus BM. Primary cardiac tumors. In: Goldhaber SZ, Braunwald E, editors. Cardiopulmonary Diseases and Cardiac Tumors: Atlas of Heart Diseases. Philadelphia: Current Medicine; 1995. p. 15.1-15.22.
3. Colucci WS, Schoen FJ. Primary tumors of the heart. In: Braunwald E, Zipes DP, Libby P, editors. Heart Disease. A Textbook of Cardiovascular Medicine. 6thed. Philadelphia: W. B. Saunders Co.; 2001. p. 1807-22.
4. Percell RL Jr, Henning RJ, Siddique Patel M. Atrial myxoma: Case report and a review of the literature. Heart Dis 2003;5:224-30.
5. MacGowan SW, Sidhu P, Aherne T, Luke D, Wood AE, Neligan MC, et al. Atrial myxoma: National incidence, diagnosis and surgical management. Ir J Med Sci 1993;162:223-6.
6. Ekinci EI, Donnan GA. Neurological manifestations of cardiac myxoma: A review of the literature and report of cases. Intern Med J 2004;34:243-9.
7. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001;80:159-72.
8. Mendoza CE, Rosado MF, Bernal L. The role of interleukin6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J 2001;28:3-7.
9. Keeling IM, Oberwalder P, Anelli-Monti M, Schuchlenz H, Demel U, Tilz GP, et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 2002;22:971-7.
10. Braunwald E, Zipes DP, Libby P. Heart Disease: A Textbook of Cardiovascular Medicine. 6thed. Philadelphia: WB Saunders; 2001.
11. Mu¨gge A, Daniel WG, Haverich A, Lichtlen PR. Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardiography. Comparison of the transthoracic and transesophageal approaches. Circulation 1991;83:70-8
12. Yuan S-M, Humuruola G. Stroke of a cardiac myxoma origin. Rev Bras Cir Cardiovasc 2015; 30:225–348
13. He D-K, Zhang Y-F, Liang Y, Ye S-X, Wang C, Kang B, et al. Risk factors for embolism in cardiac myxoma: a retrospective ana- lysis. Med Sci Monit2015; 21:1146–54.
14. Singh SD, Lansing AM. Familial cardiac myxoma–a comprehensive review of reported cases. J Ky Med Assoc 1996; 94: 96–104.
15. Mir IA, Ghani Ahangar A. Atrial myxoma: a review. Int J Community Med 2016; 3:23–9.
16. Lee KS, Kim GS, Jung Y, Jeong IS, Na KJ, Oh BS, et al. Surgical re- section of cardiac myxoma-a 30-year single institutional ex- perience. J Cardiothorac Surg 2017; 12:18.
Pinninti M, B.Syandhika,Kasturi RR,Mudgalkar N, Baviskar A. Left Atrial Myxoma Presenting As a Stroke – An Unusual Case Scenario. Perspectives in Medical Research 2021; 9 (1):84-86 DOI:10.47799/pimr.0901.17